thyroid medication and glp 1 glp-1 cancer risk No Increased for in Diabetic Patients Prescribed Medications Compared to Those Prescribed Insulin Semaglutide: What we know about – GLP-1 Therapy with Thyroid Conditions

In this context, GLP-1R agonists show remarkable potential as an emerging therapeutic agent.GLP-1R agonists reduce body weight, lower blood pressure, and improve lipid levels, as well as exerting anti-inflammatory and antioxidant effects by directly acting on GLP-1R in the heart and blood vessels, thereby reducing the risk of atherosclerotic thrombotic events (Solini et al., 2023)

10.1016/j.bbrc.2010.12.131 21 HamalS.CherukuriL.ShaikhK.KinningerA.DoshiJ.BirudarajuD.et al (2020)

In fact, after ~68 weeks on the drug, roughly 40% of the weight is regained within 3 months of stopping the medication

Holding One Preprocedure Dose of GLP-1 Agonists Before Endoscopy, Clin Gastroenterol Hepatol (2026) [PubMed abstract] Preoperative evaluation

Res 72 , 603612 (2003)

Gao, Z., Wei, Y